5-HTP通过细胞内内皮5-HTRs抑制eosinophilia;5-HTRs中的SNP与喘性肺功能有关
Matthew T Walker1, Jeffrey C Bloodworth2,3, Timothy S Kountz1
1Allergy-Immunology Division, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
Frontiers in allergy
|June 7, 2024
概括
5HTP通过影响内皮细胞中的血清素受体 (HTRs) 来减少过敏性肺炎. HTR 的遗传变异与喘患者的肺功能减弱有关.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 遗传学 遗传学 是一个
背景情况:
- 5-基托 (5HTP) 是一种血清素前体,通过减少乙氨基基基的迁移来抑制过敏性肺炎.
- 血清素受体 (HTR) 在这种5HTP功能中的作用以及HTR单核酸多态 (SNP) 与人类肺功能之间的关联仍然不清楚.
研究的目的:
- 调查血清素受体是否调解5HTP的抗炎作用.
- 为了确定HTR SNP是否与人类喘队列中的肺功能有关.
主要方法:
- 评估了使用qPCR,西斑,共聚焦显微镜,药理抑制剂和siRNA在内皮细胞和异osinophils中敲除的血清激素受体亚型.
- 在CHIRAH和GALA人类喘队伍中检查了HTR SNP.
主要成果:
- 在内皮细胞中抑制HTR1A或HTR1B会取消5HTP对氨基细胞迁移的影响,而对氨基细胞的淘汰并没有影响.
- 在内皮细胞中,细胞内发现了HTRs,而细胞外的血清激素并没有抑制迁移.
- HTR SNPs的多基因指数与喘患者的下肺功能有关.
结论:
- 血清素受体调解5HTP抑制乙酸氨基细胞的透细胞迁移.
- HTR SNP与喘中的肺功能减弱有关,这表明过敏性炎症的潜在治疗点.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
276
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
276
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
271
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
271
Asthma: Pathogenesis and Management
386
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
386
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Methylxanthines
216
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
216


